These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33947200)

  • 1. Statin therapy is associated with epigenetic modifications in individuals with Type 2 diabetes.
    Schrader S; Perfilyev A; Martinell M; García-Calzón S; Ling C
    Epigenomics; 2021 Jun; 13(12):919-925. PubMed ID: 33947200
    [No Abstract]   [Full Text] [Related]  

  • 2. Epigenetic Link Between Statin Therapy and Type 2 Diabetes.
    Ochoa-Rosales C; Portilla-Fernandez E; Nano J; Wilson R; Lehne B; Mishra PP; Gao X; Ghanbari M; Rueda-Ochoa OL; Juvinao-Quintero D; Loh M; Zhang W; Kooner JS; Grabe HJ; Felix SB; Schöttker B; Zhang Y; Gieger C; Müller-Nurasyid M; Heier M; Peters A; Lehtimäki T; Teumer A; Brenner H; Waldenberger M; Ikram MA; van Meurs JBJ; Franco OH; Voortman T; Chambers J; Stricker BH; Muka T
    Diabetes Care; 2020 Apr; 43(4):875-884. PubMed ID: 32033992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic patterns of blood lipids and DNA methylation in response to statin therapy.
    Qin X; Wang Y; Pedersen NL; Tang B; Hägg S
    Clin Epigenetics; 2022 Nov; 14(1):153. PubMed ID: 36443870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenome-wide association study (EWAS) on lipids: the Rotterdam Study.
    Braun KVE; Dhana K; de Vries PS; Voortman T; van Meurs JBJ; Uitterlinden AG; ; Hofman A; Hu FB; Franco OH; Dehghan A
    Clin Epigenetics; 2017; 9():15. PubMed ID: 28194238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase 9 promoter hypomethylation associated with adipocyte dysfunction is a statin-related metabolic effect.
    Khamis A; Boutry R; Canouil M; Mathew S; Lobbens S; Crouch H; Andrew T; Abderrahmani A; Tamanini F; Froguel P
    Clin Epigenetics; 2020 May; 12(1):68. PubMed ID: 32410704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins: Epidrugs with effects on endothelial health?
    Mohammadzadeh N; Montecucco F; Carbone F; Xu S; Al-Rasadi K; Sahebkar A
    Eur J Clin Invest; 2020 Dec; 50(12):e13388. PubMed ID: 32854143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation of insulin action and secretion - role in the pathogenesis of type 2 diabetes.
    Ling C
    J Intern Med; 2020 Aug; 288(2):158-167. PubMed ID: 32363639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of global and regional DNA methylation and histone modifications in glycemic traits and type 2 diabetes: A systematic review.
    Muka T; Nano J; Voortman T; Braun KVE; Ligthart S; Stranges S; Bramer WM; Troup J; Chowdhury R; Dehghan A; Franco OH
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):553-566. PubMed ID: 27146363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Subgroups of Type 2 Diabetes Display Different Epigenetic Patterns That Associate With Future Diabetic Complications.
    Schrader S; Perfilyev A; Ahlqvist E; Groop L; Vaag A; Martinell M; García-Calzón S; Ling C
    Diabetes Care; 2022 Jul; 45(7):1621-1630. PubMed ID: 35607770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleiotropic and Adverse Effects of Statins-Do Epigenetics Play a Role?
    Allen SC; Mamotte CDS
    J Pharmacol Exp Ther; 2017 Aug; 362(2):319-326. PubMed ID: 28576976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of outpatients at specialist clinics.
    Morieri ML; Avogaro A; Fadini GP;
    Cardiovasc Diabetol; 2020 Nov; 19(1):190. PubMed ID: 33172454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin use and risk for type 2 diabetes: what clinicians should know.
    Maki KC; Diwadkar-Navsariwala V; Kramer MW
    Postgrad Med; 2018 Mar; 130(2):166-172. PubMed ID: 29139315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Patterns in Blood Associated With Lipid Traits Predict Incident Coronary Heart Disease Events and Are Enriched for Results From Genome-Wide Association Studies.
    Hedman ÅK; Mendelson MM; Marioni RE; Gustafsson S; Joehanes R; Irvin MR; Zhi D; Sandling JK; Yao C; Liu C; Liang L; Huan T; McRae AF; Demissie S; Shah S; Starr JM; Cupples LA; Deloukas P; Spector TD; Sundström J; Krauss RM; Arnett DK; Deary IJ; Lind L; Levy D; Ingelsson E
    Circ Cardiovasc Genet; 2017 Jan; 10(1):e001487. PubMed ID: 28213390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
    Reiner Z
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism of CYP3A4 2 and eNOS genes in the diabetic patients with hyperlipidemia undergoing statin treatment.
    Jamil K; Kandula V; Kandula R; Asimuddin M; Joshi S; Yerra SK
    Mol Biol Rep; 2014 Oct; 41(10):6719-27. PubMed ID: 24996290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation of loci within ABCG1 and PHOSPHO1 in blood DNA is associated with future type 2 diabetes risk.
    Dayeh T; Tuomi T; Almgren P; Perfilyev A; Jansson PA; de Mello VD; Pihlajamäki J; Vaag A; Groop L; Nilsson E; Ling C
    Epigenetics; 2016 Jul; 11(7):482-8. PubMed ID: 27148772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative contributions of statin intensity, achieved low-density lipoprotein cholesterol level, and statin therapy duration to cardiovascular risk reduction in patients with type 2 diabetes: population based cohort study.
    Kim JY; Choi J; Kim SG; Kim NH
    Cardiovasc Diabetol; 2022 Feb; 21(1):28. PubMed ID: 35193571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel epigenetic determinants of type 2 diabetes in Mexican-American families.
    Kulkarni H; Kos MZ; Neary J; Dyer TD; Kent JW; Göring HH; Cole SA; Comuzzie AG; Almasy L; Mahaney MC; Curran JE; Blangero J; Carless MA
    Hum Mol Genet; 2015 Sep; 24(18):5330-44. PubMed ID: 26101197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced oxidized LDL in T2D plaques is associated with a greater statin usage but not with future cardiovascular events.
    Singh P; Goncalves I; Tengryd C; Nitulescu M; Persson AF; To F; Bengtsson E; Volkov P; Orho-Melander M; Nilsson J; Edsfeldt A
    Cardiovasc Diabetol; 2020 Dec; 19(1):214. PubMed ID: 33317535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin diabetogenicity: guidance for clinicians.
    Ray K
    Cardiovasc Diabetol; 2013; 12 Suppl 1(Suppl 1):S3. PubMed ID: 23819776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.